4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Agenda

Day 1 Nov 09, 2016

9:00 AM — 9:10 AM

Welcome Remarks

9:10 AM — 9:30 AM

Key Note

9:30 AM — 10:30 AM

Session 1: Regulatory Outlook for Europe

10:30 AM — 11:00 AM

Refreshment Break

11:00 AM — 12:30 PM

Session 2: Regulatory Outlook for Other Regions

12:30 PM — 1:30 PM

Lunch

1:30 PM — 3:00 PM

Session 3: Biosimilar Medicines in Clinical Use – Case Studies and Real-World Evidence

3:00 PM — 3:30 PM

Refreshment Break

3:30 PM — 5:00 PM

Session 4: Communicating to Healthcare Professionals and Patients - Stakeholder Education

Day 2 Nov 10, 2016

9:00 AM — 9:20 AM

Numeracy and the Understanding of Clinical Trials with Biosimilars

9:30 AM — 11:30 AM

Session 5: Pharmacovigilance

11:30 AM — 12:00 PM

Refreshment Break

12:00 PM — 1:30 PM

Session 5: Pharmacovigilance continued

1:30 PM — 2:30 PM

Lunch

2:30 PM — 4:30 PM

Session 6: Convergence of Regulatory Science and Medical Practice: Are We On Track?

Have an account?

4th European Biosimilars Conference

Agenda

Be informed and stay engaged.